Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification.
Rebeca San MartinPriyojit DasJacob T SandersAshtyn M HillRachel Patton McCordPublished in: eLife (2022)
The expression of a mutant Lamin A, progerin, in Hutchinson-Gilford Progeria Syndrome leads to alterations in genome architecture, nuclear morphology, epigenetic states, and altered phenotypes in all cells of the mesenchymal lineage. Here, we report a comprehensive analysis of the transcriptional status of patient derived HGPS fibroblasts, including nine cell lines not previously reported, in comparison with age-matched controls, adults, and old adults. We find that Progeria fibroblasts carry abnormal transcriptional signatures, centering around several functional hubs: DNA maintenance and epigenetics, bone development and homeostasis, blood vessel maturation and development, fat deposition and lipid management, and processes related to muscle growth. Stratification of patients by age revealed misregulated expression of genes related to endochondral ossification and chondrogenic commitment in children aged 4-7 years old, where this differentiation program starts in earnest. Hi-C measurements on patient fibroblasts show weakening of genome compartmentalization strength but increases in TAD strength. While the majority of gene misregulation occurs in regions which do not change spatial chromosome organization, some expression changes in key mesenchymal lineage genes coincide with lamin associated domain misregulation and shifts in genome compartmentalization.
Keyphrases
- genome wide
- poor prognosis
- gene expression
- dna methylation
- mesenchymal stem cells
- extracellular matrix
- bone marrow
- transcription factor
- case report
- stem cells
- copy number
- end stage renal disease
- genome wide identification
- newly diagnosed
- skeletal muscle
- induced apoptosis
- binding protein
- chronic kidney disease
- ejection fraction
- quality improvement
- adipose tissue
- prognostic factors
- cell death
- genome wide analysis
- heat shock
- umbilical cord
- cell therapy
- soft tissue
- cell free
- heat shock protein
- clinical evaluation